The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Discovery and development of new antibiotics: the problem of antibiotic resistance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
The Molecular Basis of Antibiotic Action
Gale, E. F. (1981) · Medical Entomology and Zoology · Cited by 1,217
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Fluoroquinolone antimicrobial agents
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.4.378 · Cited by 649
Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W. T., Cooper, C. S., Rosen, T., & Pernet, A. G. (1989) · Biochemistry · doi:10.1021/bi00435a039 · Cited by 413
Cohen, S. P., McMurry, L. M., & Levy, S. B. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.12.5416-5422.1988 · Cited by 300
Mechanisms of action of and resistance to ciprofloxacin.
Hooper, D. C., Wolfson, J. S., Ng, E. Y., et al. (1987) · PubMed · Cited by 265
Beta-lactamase inhibitors from laboratory to clinic
Bush, K. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.109 · Cited by 212
Weisblum, B. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.63 · Cited by 196
Nikaido, H., & Rosenberg, E. Y. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1361-1367.1990 · Cited by 164
Curtis, N. A. C., Eisenstadt, R. L., East, S. J., Cornford, R. J., Walker, L., & White, A. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1879 · Cited by 137
Bacterial Resistance to Quinolones: Mechanisms and Clinical Importance
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_5.s960 · Cited by 107
Screening of natural products for antimicrobial agents
Silver, L. L., & Bostian, K. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01964283 · Cited by 104
Self-citationIn vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor
Coleman, K., Griffin, D. R., Page, J., & Upshon, P. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1580 · Cited by 96
Silley, P., Griffiths, J., Monsey, D., & Harris, A. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1806 · Cited by 71
On the nature of antibiotic binding sites in ribosomes
Cundliffe, E. (1987) · Biochimie · doi:10.1016/0300-9084(87)90213-6 · Cited by 63
Mechanism of quinolone mutagenicity in bacteria
Gocke, E. (1991) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(91)90095-6 · Cited by 59
Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB
Étienne, J., Gerbaud, G., Fleurette, J., & Courvalin, P. M. (1991) · FEMS Microbiology Letters · doi:10.1016/0378-1097(91)90406-z · Cited by 52
Bacterial resistance to antibiotics as a function of outer membrane permeability
Nikaido, H. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_a.17 · Cited by 49
Mode of action of the dual-action cephalosporin Ro 23-9424
Georgopapadakou, N. H., Bertasso, A., Chan, K. K., et al. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.7.1067 · Cited by 46
McMurry, L. M., Cullinane, J. C., & Levy, S. B. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.791 · Cited by 46
Smith, D. R., & Calvo, J. M. (1982) · Molecular and General Genetics MGG · doi:10.1007/bf00384386 · Cited by 44
In-vitro selection of bacteria resistant to the 4-quinolone agents
Limb, D. I., Dabbs, D. J. W., & Spencer, R. C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.1.65 · Cited by 39
Serious Infection in an Adult due to Penicillin-Tolerant Group B Streptococcus
Steinbrecher, U. P. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340130152036 · Cited by 33
Two forms of antimicrobial resistance: bacterial persistence and positive function resistance
Bryan, L. E. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/23.6.817 · Cited by 33
Newer Penicillins and Beta-Lactamase Inhibitors
Bush, L. M., Calmon, J., & Johnson, C. C. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30290-7 · Cited by 26
Smith, D. A., McFadden, H. W., & Miller, N. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.851 · Cited by 5
Cited by
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Screening methods to determine antibacterial activity of natural products
Valgas, C., Souza, S. M. D., Smânia, E. F. A., & Smânia Jr., A. (2007) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822007000200034 · Cited by 1,403
“Because of available antimicrobials failure to treat infectious diseases, many researchers have focused on the investigation of natural products as source of new bioactive molecules (15,17).”
BackgroundChallenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Self-citationResistance to Antibiotics Mediated by Target Alterations
Spratt, B. G. (1994) · Science · doi:10.1126/science.8153626 · Cited by 674
Metadata
- Authors
- Silver, L. L., & Bostian, K. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1993-03
- Volume
- 37
- Issue
- 3
- Pages
- 377-383
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2079762396
- Cited by
- 253
- References
- 28
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.